Topical issues of introduction of criminal offenses in the legislation of Ukraine
openaire +1 more source
A response to "Surveillance is not safety: a response to Dewa and colleagues' paper about passive remote monitoring technology (Oxevision)". [PDF]
Dewa LH +4 more
europepmc +1 more source
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay +5 more
wiley +1 more source
Information and counselling on post-mortem reproduction: a Delphi study with ART specialists. [PDF]
Rodrigues M, Silvestre M, V Martins M.
europepmc +1 more source
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
The right to be forgotten and workers' health protection: a critical balancing act. [PDF]
Garzillo EM, Monaco MGL.
europepmc +1 more source
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden +3 more
wiley +1 more source
Editorial: Repurposing for small population needs. [PDF]
Giannuzzi V +3 more
europepmc +1 more source
Decoding RNA regulation: Challenges and opportunities for RNA‐based therapies in Europe
Abstract RNA‐based medicinal products represent a promising frontier in personalised medicine, offering sequence‐specific disease targeting at various molecular levels, yet their clinical translation in the European Union (EU) may be hindered by regulatory uncertainty around definitions and evidence requirements; this study therefore aims to identify ...
Olivia C. Lewis +4 more
wiley +1 more source
Exploring perspectives of Scottish medical students on the proposed 'Assisted Dying for Terminally Ill Adults (Scotland)' Bill. [PDF]
Geddes D, Knox J, Obree D, Harden J.
europepmc +1 more source

